From A to Z on Hepatitis C in Thalasemia

Last Update: 19 June, 2022 | 13:14

Introduction of this book: 

Thalassemia patients have a high prevalence  of hepati• tis C virus (HCV) infections. Recent improvements in the survival of these patients are a result of more services for the control of iron overload, the provision  of safe blood, and better control of complications. Today,  liver disease is the  main  cause  of mortality in thalassemia patients throughout the  world. Unfortunately, there  are  inade• quate policy in most thalassemia centers for the control of HCV infections. Thalassemia patients with HCV infec• tions  pose  a real  dilemma in the  management of this infection, and  they  must  have access to  adequate pro• fessional  counseling from health care workers, in addi• tion, the health system should  provide appropriate diag• nostic  and  therapeutic options. Therefore,  I  considered it imperative to provide  a book  from  A to Z  for health professionals regarding the epidemiology, screening, diagnosis  and  treatment of HCV infection in this  high risk group. My hope  is for improvements  in the control of HCV in thalassemia patients in the world, especially in the Mediterranean region.

 

CHAPTER 1:
07 Virology

CHAPTER 2:
12 Epidemiology

CHAPTER 3:
26 Natural History

CHAPTER 4:
34 Diagnosis and  evaluation

CHAPTER 5:
42 Treatment

 

Book Details: 

 

  • Author: Dr. Seyed-Moayed Alavian
  • Publisher: Pouyan Kowsar Health Publishing Company; 1st edition ( April 8, 2022)
  • Publication Date: April 8, 2022
  • Print Length: 78 pages
  • Language: English
  • ISBN: 978-622-99114-6-4
  • Sponsored by: Salamat Pooyan 

 

Indexing Sources for STM Journals
Indexing Sources for STM Journals, Authors: SM Miri, SM Alavian